Unknown PHASE4 INTERVENTIONAL 2-arm NCT04379219

Surgery Alone Versus Methotrexate Before Surgery in Cesarean Scar Pregnancy

Surgery Alone Versus Methotrexate Before Surgery in Cases of First Trimester Cesarean Scar Pregnancy: a Randomized Controlled Trial

Sponsor: Mansoura University

Conditions Cesarean Scar Pregnancy

Interventions Methotrexate

Updated 6 times since 2020 Last updated: May 4, 2020 Started: Dec 1, 2019 Primary completion: Aug 31, 2020 Completion: Dec 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04379219, this PHASE4 trial focuses on Cesarean Scar Pregnancy and remains ongoing. Sponsored by Mansoura University, it has been updated 6 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jun 2022 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jan 2021 — Jun 2022 [monthly]

Recruiting PHASE4

▶ Show 1 earlier version

Jun 2020 — Jan 2021 [monthly]

Recruiting PHASE4

First recorded

Dec 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mansoura University

Data source: Mansoura University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Al Mansurah, Egypt